PremiumThe FlyMedtronic’s Altaviva and Symplicity Spyral Systems granted Category I CPT Codes12h agoMDT
PremiumCompany AnnouncementsBMY Terminates Early Leukemia Trial, Trimming One Risky Bet From Its Oncology Pipeline15h agoBMY
PremiumCompany AnnouncementsUnilever Updates Share Capital and Voting Rights for Investor Disclosure17h ago
PremiumRatingsBristol-Myers Squibb: Pipeline Risks Balance Core Strengths, Justifying Hold Rating and Unchanged $60 Price Target20h agoBMY
Bristol-Myers Squibb: Pipeline Risks Balance Core Strengths, Justifying Hold Rating and Unchanged $60 Price Target